SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
奔跑的考拉
Lv3
1
330 积分
2024-02-06 加入
最近求助
最近应助
互助留言
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2小时前
已完结
Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer
2小时前
已完结
Deep learning based on ultrasound to differentiate pathologically proven atypical and typical medullary thyroid carcinoma from follicular thyroid adenoma
4天前
已完结
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
4天前
已完结
Clinical and Surgical Year in Review
23天前
已完结
18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
26天前
已完结
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival
26天前
已完结
BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
26天前
已完结
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol
26天前
已完结
Redifferentiating Effect of Larotrectinib in NTRK-Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer
26天前
已完结
没有进行任何应助
下到了【积分已退回】
5个月前
这不是文章【积分已退回】
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论